These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3849413)

  • 41. Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses.
    Frydman R; Fernandez H; Pons JC; Ulmann A
    Hum Reprod; 1988 Aug; 3(6):803-6. PubMed ID: 3065355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens.
    Birgerson L; Odlind V
    Contraception; 1988 Oct; 38(4):391-400. PubMed ID: 3208513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interception. III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women.
    van Santen MR; Haspels AA
    Contraception; 1987 May; 35(5):423-31. PubMed ID: 3040334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Steroid anti-hormones: anti-progesterone activity of RU 486 and its contragestational and other applications].
    Baulieu EE; Ulmann A
    Bull Acad Natl Med; 1985 Nov; 169(8):1191-9. PubMed ID: 3914335
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
    Dao B; Vanage G; Li XJ; Bardin CW; Koide SS
    Contraception; 1997 Jan; 55(1):35-40. PubMed ID: 9013059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of prostaglandins and antiprogestins for pregnancy termination.
    Bygdeman M; Van Look PF
    Int J Gynaecol Obstet; 1989 May; 29(1):5-12. PubMed ID: 2566529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
    Elger W; Fähnrich M; Beier S; Qing SS; Chwalisz K
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1065-74. PubMed ID: 3479025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combined use of prostaglandin and antiprogestin in human fertility control.
    Baulieu EE
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():55-62. PubMed ID: 7732905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost).
    Rodger MW; Logan AF; Baird DT
    Contraception; 1989 May; 39(5):497-502. PubMed ID: 2656087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of two antiprogestins on early pregnancy in the long-tailed macaque (Macaca fascicularis).
    Tarantal AF; Hendrickx AG; Matlin SA; Lasley BL; Gu QQ; Thomas CA; Vince PM; Van Look PF
    Contraception; 1996 Aug; 54(2):107-15. PubMed ID: 8842588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion?
    Gupta JK; Johnson N
    Contraception; 1992 Nov; 46(5):489-97. PubMed ID: 1458895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary results with the antiprogestational compound RU-486 (mifepristone) for interruption of early pregnancy.
    Vervest HA; Haspels AA
    Fertil Steril; 1985 Nov; 44(5):627-32. PubMed ID: 2414136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.
    Baulieu EE
    Ann N Y Acad Sci; 1997 Sep; 828():47-58. PubMed ID: 9329823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Rodger MW; Baird DT
    Contraception; 1989 Oct; 40(4):439-47. PubMed ID: 2582769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The efficacy of oral Mifepristone (RU 38,486) with a prostaglandin E1 analog vaginal pessary for the termination of early pregnancy: complications and patient acceptability.
    Hill NC; Ferguson J; MacKenzie IZ
    Am J Obstet Gynecol; 1990 Feb; 162(2):414-7. PubMed ID: 1689961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of abortion in early first trimester human pregnancy using epostane.
    Webster MA; Gillmer MD
    Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid antagonists and receptor-associated proteins.
    Lebeau MC; Baulieu EE
    Hum Reprod; 1994 Mar; 9(3):437-44. PubMed ID: 8006131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen and progesterone receptors in human decidua after RU486 treatment.
    Shi WL; Wang JD; Fu Y; Zhu PD
    Fertil Steril; 1993 Jul; 60(1):69-74. PubMed ID: 8513961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.